Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-25 @ 9:30 PM
Study NCT ID:
NCT01834651
Status:
COMPLETED
Last Update Posted:
2017-09-27
First Post:
2013-04-01
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase II Study of Cabozantinib (XL184) Therapy in Castrate Resistant Prostate Cancer (CRPC) With Visceral Metastases
Sponsor:
Edwin Posadas, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-04-30
Start Date Type:
ACTUAL
Primary Completion Date:
2016-07-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-07-18
Completion Date Type:
ACTUAL
First Submit Date:
2013-04-01
First Submit QC Date:
None
Study First Post Date:
2013-04-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-07-16
Results First Submit QC Date:
None
Results First Post Date:
2017-09-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-31
Last Update Post Date:
2017-09-27
Last Update Post Date Type:
ACTUAL